SV2A in Older Adults
NCT05465538 · Status: RECRUITING · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL · Enrollment: 24
Last updated 2026-02-27
Summary
The aim of the study is to examine the effect of cannabis use on brain synaptic density among older adults using \[11C\]UCB-J PET imaging.
Conditions
- Cannabis Use
Interventions
- DRUG
-
[11C]UCB-J PET
Single PET scan using the radioligand \[11C\]UCB-J
Sponsors & Collaborators
-
National Institute on Drug Abuse (NIDA)
collaborator NIH -
Yale University
lead OTHER
Principal Investigators
-
Deepak C D'Souza, MBBS, MD · Yale University
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- OTHER
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 50 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2022-07-06
- Primary Completion
- 2026-12-30
- Completion
- 2027-09-30
- FDA Drug
- Yes
Countries
- United States
Study Locations
More Related Trials
-
Varenicline Treatment for Cannabis Use Disorder
NCT02892110 ·Status: COMPLETED ·Phase: PHASE2
-
Cannabinoids and Cerebellar-Motor Functioning
NCT01853020 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
The Tolerability and Effects of AZD0530 in Individuals With or Without a Family History of Alcoholism
NCT02262026 ·Status: COMPLETED ·Phase: PHASE1
-
Cannabis Observations on Brain Waves, Retrieval, and Attention: Experiment 3
NCT06669585 ·Status: COMPLETED
-
Cerebellar Alterations in Individuals With a Cannabis Use Disorder
NCT02816034 ·Status: COMPLETED ·Phase: NA
-
Cannabis and Aging
NCT05084105 ·Status: COMPLETED
-
Ketamine/Placebo Family History Positive Study
NCT00588952 ·Status: COMPLETED ·Phase: NA
-
UH3 Varenicline for Cannabis Use Disorder
NCT03980561 ·Status: COMPLETED ·Phase: PHASE2
-
Abuse Potential of Sativex
NCT01323569 ·Status: COMPLETED ·Phase: PHASE1
-
Using Imaging to Assess Effects of THC on Brain Activity
NCT03655717 ·Status: COMPLETED ·Phase: NA
-
Clinical and Neurobiological Effects of Cannabis Dependence in Young Adults
NCT00656487 ·Status: COMPLETED ·Phase: PHASE2
-
Ketamine Alcohol (in Treatment-Resistant Depression)
NCT02122562 ·Status: RECRUITING ·Phase: PHASE2
-
Imaging Cannabinoid CB1 Receptors in Alcohol Dependence
NCT00816439 ·Status: COMPLETED
-
Psilocybin-Assisted vs Ketamine-Assisted Psychotherapy for Alcohol Use Disorder
NCT05421065 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
[C-11]PiB PET Imaging in Alcohol Use Disorders
NCT03746366 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Phenotyping Patients With Alcohol and Cannabis Use Disorders Using the Addictions Neuroclinical Assessment
NCT05855668 ·Status: RECRUITING ·Phase: NA
-
Study of the Effectiveness of Quetiapine for the Treatment of Alcohol Dependency
NCT00498628 ·Status: COMPLETED ·Phase: PHASE2
-
Neural Correlates of Driving and Cannabis
NCT03581058 ·Status: UNKNOWN ·Phase: PHASE1
-
Cannabidiol in Youth Alcohol Use Disorder
NCT05317546 ·Status: COMPLETED ·Phase: PHASE2
-
Defining Neurobiological Links Between Substance Use and Mental Illness
NCT05538910 ·Status: RECRUITING ·Phase: NA
-
Family History Study of Alcohol Consumption Using Memantine
NCT00630955 ·Status: COMPLETED ·Phase: PHASE2
-
Effectiveness of Cognitive Therapy for Suicide Attempters With Drug Dependence Disorder
NCT00218725 ·Status: COMPLETED ·Phase: PHASE1
-
Safety and Efficacy of a FAAH-Inhibitor to Treat Cannabis Withdrawal
NCT01618656 ·Status: COMPLETED ·Phase: PHASE2
-
Combining Non-Invasive Brain Stimulation With Cognitive Behavioral Intervention in Substance Use Disorder
NCT02570763 ·Status: WITHDRAWN ·Phase: NA
-
Multimodal Neuroimaging of Stress and Reward Cues to Assess Alcoholism Risk and Relapse
NCT02616094 ·Status: COMPLETED ·Phase: NA